Chinese herbal medicine for subfertile women with polycystic ovarian syndrome - PubMed (original) (raw)
Review
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Jing Zhang et al. Cochrane Database Syst Rev. 2010.
Update in
- Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K, Zhang J, Xu L, Wu T, Lim CE. Zhou K, et al. Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3. Cochrane Database Syst Rev. 2016. PMID: 27731904 Free PMC article. Updated. Review.
Abstract
Background: Polycystic ovarian syndrome (PCOS) is one of the most common reproductive endocrinology abnormalities, affecting 5% to 10% of women of reproductive age. Western medicines, such as oral contraceptives and insulin sensitizers, have been widely used to improve the symptoms and signs for PCOS. Recently, many studies have been published considering Chinese herbal medicine (CHM) as an alternative treatment for women with PCOS.
Objectives: To evaluate the efficacy and safety of Chinese medicinal herbs for subfertile women with PCOS.
Search strategy: We searched the following databases (from inception to March 2010): Menstrual Disorders and Subfertility Group Specialised Register (MDSG), Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Allied and Complementary Medicine (AMED), PsycINFO, Chinese National Knowledge Infrastructure (CNKI), VIP, Wanfang. In addition, all reference lists of included trials were searched and experts in the field were contacted to locate trials.
Selection criteria: Randomized controlled trials (RCT) considering the use of CHM for the treatment of subfertile women with PCOS.
Data collection and analysis: Two review authors independently screened appropriate trials for inclusion, assessed methodological quality, and extracted data. We contacted primary authors for additional information. Meta-analysis was conducted. Odds ratio (OR) was used for reporting dichotomous data with 95% confidence intervals (CI).
Main results: Four RCTs involving 344 participants were included. The methodological risk of bias of included studies was poor. Different interventions were used in these four RCTs.There was evidence of statistically significant difference seen improving pregnancy rate (per woman) between CHM plus clomiphene and clomiphene (OR 2.97, 95%CI 1.71 to 5.17). However, there was no statistically significant difference seen in the other comparison groups for improving pregnancy rate (per woman).There was no evidence of statistically significant difference in improving ovulation rate (per woman) between CHM and clomiphene (OR 1.42, 95%CI 0.19 to 10.49), between CHM plus laparoscopic ovarian drilling (LOD) and LOD (OR 2.43, 95%CI 0.39 to 15.08).There were not statistically significant difference between CHM plus follicle aspiration, ovulation induction and follicle aspiration plus ovulation induction for adverse events including LUFS, OHSS and multiple pregnancy.Live birth rate was not reported by any studies.
Authors' conclusions: There is limited evidence that the addition of CHM to clomiphene is associated with improved clinical pregnancy outcomes and no other evidence of any other effect. The methodology of RCTs was not adequately reported by primary studies.
Similar articles
- Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K, Zhang J, Xu L, Lim CED. Zhou K, et al. Cochrane Database Syst Rev. 2021 Jun 4;6(6):CD007535. doi: 10.1002/14651858.CD007535.pub4. Cochrane Database Syst Rev. 2021. PMID: 34085287 Free PMC article. - Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K, Zhang J, Xu L, Wu T, Lim CE. Zhou K, et al. Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3. Cochrane Database Syst Rev. 2016. PMID: 27731904 Free PMC article. Updated. Review. - Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
Franik S, Kremer JA, Nelen WL, Farquhar C. Franik S, et al. Cochrane Database Syst Rev. 2014 Feb 24;(2):CD010287. doi: 10.1002/14651858.CD010287.pub2. Cochrane Database Syst Rev. 2014. PMID: 24563180 Updated. Review. - Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Franik S, et al. Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3. Cochrane Database Syst Rev. 2018. PMID: 29797697 Free PMC article. Updated. Review. - Inositol for subfertile women with polycystic ovary syndrome.
Showell MG, Mackenzie-Proctor R, Jordan V, Hodgson R, Farquhar C. Showell MG, et al. Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012378. doi: 10.1002/14651858.CD012378.pub2. Cochrane Database Syst Rev. 2018. PMID: 30570133 Free PMC article.
Cited by
- Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhou K, Zhang J, Xu L, Lim CED. Zhou K, et al. Cochrane Database Syst Rev. 2021 Jun 4;6(6):CD007535. doi: 10.1002/14651858.CD007535.pub4. Cochrane Database Syst Rev. 2021. PMID: 34085287 Free PMC article. - Acupuncture for polycystic ovarian syndrome.
Lim CED, Ng RWC, Cheng NCL, Zhang GS, Chen H. Lim CED, et al. Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD007689. doi: 10.1002/14651858.CD007689.pub4. Cochrane Database Syst Rev. 2019. PMID: 31264709 Free PMC article. - The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. Shamasbi SG, et al. Eur J Nutr. 2020 Mar;59(2):433-450. doi: 10.1007/s00394-019-02033-1. Epub 2019 Jun 29. Eur J Nutr. 2020. PMID: 31256251 - Welsh Onion Root (Allium fistulosum) Restores Ovarian Functions from Letrozole Induced-Polycystic Ovary Syndrome.
Lee YH, Yang H, Lee SR, Kwon SW, Hong EJ, Lee HW. Lee YH, et al. Nutrients. 2018 Oct 4;10(10):1430. doi: 10.3390/nu10101430. Nutrients. 2018. PMID: 30287740 Free PMC article. - Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis.
Arentz S, Smith CA, Abbott J, Bensoussan A. Arentz S, et al. BMC Complement Altern Med. 2017 Nov 25;17(1):500. doi: 10.1186/s12906-017-2011-x. BMC Complement Altern Med. 2017. PMID: 29178904 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical